Babler Martin
Alumis Inc. Common Stock · President
Babler Martin is listed in public filings as director, officer: President, CEO and Chairman. This Babler Martin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Alumis Inc. Common Stock (ALMS), and Prelude Therapeutics Incorporated (PRLD). Investors use Babler Martin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $20M745.9k shares | Grant / ExerciseJan 26, 2026 | $19.6M745.9k shares | $26.31 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.6M662k shares | Grant / ExerciseJul 29, 2025 | $2.6M662k shares | $3.95 | -- | |
| $593k150k shares | Grant / ExerciseJul 29, 2025 | $592.5K150k shares | $3.95 | -- | |
| $40k38k shares | Grant / ExerciseJun 12, 2025 | $39.5K38k shares | $1.04 | -- | |
| $685k106.5k shares | BuyApr 1, 2025 | $100.7K15.7k shares | $6.44 | -- | |
| $92k23.5k shares | Grant / ExerciseJun 14, 2024 | $91.7K23.5k shares | $3.90 | -- |